Novavax Company Profile (NASDAQ:NVAX)

Analyst Ratings

Consensus Ratings for Novavax (NASDAQ:NVAX) (?)
Ratings Breakdown: 2 Hold Rating(s), 6 Buy Rating(s)
Consensus Rating:Buy (Score: 2.75)
Consensus Price Target: $13.11 (79.06% upside)

Analysts' Ratings History for Novavax (NASDAQ:NVAX)
Show:
DateFirmActionRatingPrice TargetActions
7/28/2016Citigroup Inc.Boost Price TargetBuy$10.00 -> $12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/27/2016WedbushReiterated RatingOutperform$14.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/29/2016Piper Jaffray Cos.Reiterated RatingOverweight$14.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/2/2016Chardan CapitalReiterated RatingNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/3/2016JPMorgan Chase & Co.Lower Price TargetOverweight$14.00 -> $12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/1/2016FBR & CoReiterated RatingOutperform$17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/3/2015GuggenheimInitiated CoverageMarket Perform$17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/2/2015Ladenburg ThalmannReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/7/2015Janney Montgomery ScottReiterated Rating$12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/12/2015GMP SecuritiesInitiated CoveragePositiveView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/30/2014 forward)

Earnings

Earnings History for Novavax (NASDAQ:NVAX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/8/2016        
5/4/2016Q1($0.27)($0.29)$10.39 million$4.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/29/2016Q415($0.14)($0.29)$8.07 million$5.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/9/2015Q315($0.09)($0.12)$10.59 million$6.50 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/10/2015Q215($0.09)($0.08)$9.90 million$14.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/7/2015Q115($0.11)($0.10)$9.70 million$9.88 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/26/2015Q4 14($0.08)($0.13)$9.60 million$6.70 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/5/2014Q314($0.07)($0.08)$9.20 million$8.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/6/2014Q214($0.07)($0.08)$8.74 million$8.26 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/7/2014Q114($0.07)($0.07)$3.80 million$7.50 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/10/2014Q413($0.08)($0.07)$6.22 million$8.70 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/7/2013Q313($0.06)($0.09)$4.56 million$4.80 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/8/2013Q2 2013($0.06)($0.08)$4.45 million$3.50 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/7/2013Q1 2013($0.06)($0.07)$5.54 million$3.80 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/1/2013Q4 2012($0.04)($0.06)$5.85 million$4.57 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/2/2012Q312($0.05)($0.05)$7.59 million$5.80 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/3/2012($0.07)($0.05)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/4/2012($0.04)($0.06)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/9/2012($0.04)($0.03)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/4/2011($0.06)($0.03)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/5/2011($0.08)($0.04)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/9/2011($0.07)($0.07)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/28/2011($0.09)($0.06)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Novavax (NASDAQ:NVAX)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20163($0.27)($0.13)($0.22)
Q2 20163($0.28)($0.13)($0.19)
Q3 20163($0.23)($0.16)($0.19)
Q4 20163($0.24)($0.16)($0.19)
Q1 20171($0.21)($0.21)($0.21)
Q2 20171($0.23)($0.23)($0.23)
Q3 20171($0.22)($0.22)($0.22)
Q4 20171($0.24)($0.24)($0.24)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Novavax (NASDAQ:NVAX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Novavax (NASDAQ:NVAX)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
6/6/2016Gary C EvansDirectorSell18,998$6.50$123,487.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/24/2016Gary C EvansDirectorSell50,000$5.41$270,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/31/2016Stanley C ErckCEOSell424,778$5.19$2,204,597.82View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/31/2016Barclay A. PhillipsCFOBuy405$4.38$1,773.90View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/31/2016Gregory M. GlennSVPBuy2,369$4.38$10,376.22View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/31/2016Stanley C. ErckCEOBuy2,072$4.38$9,075.36View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/16/2015John A Herrmann IIISVPSell27,945$8.64$241,444.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/24/2015Gary C EvansDirectorSell20,000$11.24$224,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/20/2015Barclay A. PhillipsCFOSell28,656$13.06$374,247.36View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/18/2015Gregory M. GlennSVPSell15,000$13.52$202,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/13/2015Gary C EvansDirectorSell6,002$13.56$81,387.12View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/18/2015James F YoungDirectorSell50,000$9.47$473,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/17/2015Rajiv I ModiDirectorSell433,053$9.01$3,901,807.53View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/11/2015Rajiv I ModiDirectorSell11,185$9.00$100,665.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/10/2015Rajiv I ModiDirectorSell551,081$8.97$4,943,196.57View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/9/2015Rajiv I ModiDirectorSell47,531$8.93$424,451.83View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/8/2015Rajiv I ModiDirectorSell206,175$8.93$1,841,142.75View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/4/2015Rajiv I ModiDirectorSell504,681$8.92$4,501,754.52View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/1/2015Rajiv I ModiDirectorSell3,500,000$8.74$30,590,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/31/2015Barclay A PhillipsCFOBuy8,388$2.28$19,124.64View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/31/2015John TrizzinoSVPBuy6,611$3.63$23,997.93View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/31/2015Stanley C ErckCEOBuy6,122$2.28$13,958.16View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/16/2014Gary C EvansDirectorSell46,701$5.72$267,129.72View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/12/2014Gary C EvansDirectorSell30,000$5.77$173,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/20/2014Rajiv I ModiDirectorSell518,889$5.02$2,604,822.78View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/18/2014Rajiv I ModiDirectorSell1,481,111$5.00$7,405,555.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/3/2014Barclay A PhillipsCFOBuy5,000$4.11$20,550.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/3/2014Timothy Jon HahnSVPBuy2,500$4.05$10,125.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/26/2014Gregory M GlennSVPSell16,809$4.16$69,925.44View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/25/2014Timothy Jon HahnSVPBuy9,000$4.17$37,530.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/31/2014Barclay A PhillipsCFOBuy8,788$2.28$20,036.64View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/31/2014Russell P WilsonSVPBuy4,989$2.28$11,374.92View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/31/2014Stanley C ErckCEOBuy6,788$2.28$15,476.64View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/17/2014John TrizzinoSVPBuy5,500$4.51$24,805.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/16/2014John TrizzinoSVPBuy16,500$4.51$74,415.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/25/2014Barclay PhillipsCFOBuy5,000$4.25$21,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/25/2014Richard DouglasDirectorBuy50,000$4.33$216,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/25/2014Stanley ErckCEOBuy10,000$4.27$42,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/21/2014Pharmaceuticals Ltd Cadilamajor shareholderSell3,000,000$4.95$14,850,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/31/2014Barclay PhillipsCFOBuy9,868$2.29$22,597.72View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/31/2014Stanley ErckCEOBuy11,868$2.29$27,177.72View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/31/2014Timothy Jon HahnSVPBuy9,416$2.29$21,562.64View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/12/2013Richard DouglasDirectorBuy50,000$1.90$95,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/10/2013Timothy Jon HahnSVPBuy21,000$1.88$39,480.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/7/2013Gregory M GlennInsiderBuy2,000$1.92$3,840.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/6/2013James F YoungDirectorBuy100,000$1.91$191,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/11/2013James F YoungDirectorBuy100,000$2.03$203,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Novavax (NASDAQ:NVAX)
DateHeadline
07/30/16 04:57 PMMost Recent Analysts Ratings Report: Novavax, Inc. (NASDAQ:NVAX) , Pernix Therapeutics Holdings, Inc. (NASDAQ ... - Street Updates
07/28/16 05:48 PMCitigroup Holds To Rating And Lowers Price Target On Novavax, Inc. (NVAX)
07/27/16 08:35 AMInvestors Traded Stocks: Novavax, Inc. (NASDAQ:NVAX) , Biodel Inc. (NASDAQ:BIOD) - Street Updates
07/27/16 08:35 AMPrice Target Highlight: Novavax, Inc. (NASDAQ:NVAX) - News Oracle
07/25/16 12:58 PM3 Top Biotech Stocks to Buy Now - Why Amgen, Celgene, and Novavax shares are screaming to be scooped up.
07/25/16 06:47 AMWhat's behind large Novavax put activity -
07/23/16 09:27 AMStocks Worth Mentioning Ratings-Wise: Novavax, Inc. (NASDAQ:NVAX), Nighthawk Energy Plc (LON:HAWK) - Review Fortune
07/22/16 05:23 PMTraders Recap: Gevo, Inc. (GEVO), Staples, Inc. (SPLS), Novavax, Inc. (NVAX)
07/21/16 05:51 PMAnalysts Observing Stocks: Novavax, Inc. (NASDAQ:NVAX) , Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) - Street Updates
07/21/16 08:27 AMWatch List: Bonanza Creek Energy Inc (NYSE:BCEI), Novavax, Inc. (NASDAQ:NVAX) - NYSE Journal (press release)
07/21/16 08:27 AMAre Analysts Bearish Novavax, Inc. (NASDAQ:NVAX) After Last Week? - Consumer Eagle
07/20/16 08:28 AMAnalysts Watching Stocks: Novavax, Inc. (NASDAQ:NVAX) , Celldex Therapeutics, Inc. (NASDAQ:CLDX) - Street Updates
07/19/16 07:52 AMAnalysts Observing Stocks: Novavax, Inc. (NASDAQ:NVAX) , Anavex Life Sciences Corp. (NASDAQ:AVXL) - Street Updates
07/18/16 10:56 AMAnalysts Observing Stocks: Novavax, Inc. (NASDAQ:NVAX) , Relypsa, Inc. (NASDAQ:RLYP) - Street Updates
07/18/16 10:56 AMeBay Inc (NASDAQ:EBAY) & Novavax, Inc. (NASDAQ:NVAX) Notable Runners - Money News (press release)
07/15/16 10:24 AMWill Novavax, Inc. (NASDAQ:NVAX) Surprise Analysts? - Investor Newswire
07/15/16 10:24 AMNovavax Inc Realized Volatility Hits Extreme Level - CML News
07/14/16 11:31 AMCan Novavax Regain Its Former Glory? - Here's why this beaten-down biotech stock could come roaring back soon.
07/14/16 09:07 AMStocks Trending Alert: Novavax, Inc. (NVAX), EPIRUS Biopharmaceuticals, Inc. (EPRS), Host Hotels & Resorts, Inc. (HST) - iStreetWire
07/14/16 09:07 AMInvestors Spotlight: Valeant Pharmaceuticals International, Inc. (NYSE:VRX) , Novavax, Inc. (NASDAQ:NVAX) - Street Updates
07/14/16 09:07 AMTime To Put On The Watch List? - Novavax, Inc. (NASDAQ:NVAX), Vertex Pharmaceuticals Incorporated (NASDAQ ... - The Voice Registrar
07/14/16 09:07 AMHC Stocks News Alerts: Novavax, Inc. (NASDAQ:NVAX), Skyline Medical Inc (NASDAQ:SKLN) - share market updates (press release)
07/13/16 02:40 PMWhy Novavax, Inc. Stock Rose 18.4% in June - Continued optimism for its lead vaccine candidate and some post-Brexit bargain shopping lifted the biotech stock.
07/12/16 09:52 AMTrading the Biotech News: Eleven Biotherapeutics (EBIO), Novavax (NASDAQ:NVAX) - The Voice Registrar
07/12/16 09:52 AMHC Stocks Alerts: Immunomedics, Inc. (NASDAQ:IMMU), Novavax, Inc. (NASDAQ:NVAX) - share market updates (press release)
07/11/16 05:33 PMAnalyst's Valuable Buzzers: Pfizer, Inc. (NYSE:PFE) , Novavax, Inc. (NASDAQ:NVAX) - Street Updates
07/11/16 10:16 AMU.S. Companies On Hiring Sprees Across The Country - As June’s blowout jobs report last Friday made abundantly clear, U.S. companies have not lost their appetite for hiring. In recent weeks, several U.S. companies have announced plans to bring hundreds of new jobs to communities around the country. Novavax, Inc. (NASDAQ: NVAX) recently announced it will be adding 850 new jobs in Gaithersburg, Maryland, as it expands its R&D business. Pilgrim’s Pride Corporation (NASDAQ: PPC) has announced a $24 million expansion that will create about 140 jobs near Frankfort, Kentucky. In Aurora, ...Full story available on Benzinga.com
07/10/16 04:55 PMStock Performance Rundown on: Novavax, Inc. (NASDAQ:NVAX) - Press Telegraph
07/09/16 04:58 PMCan Novavax, Inc. (NASDAQ:NVAX) Surprise Analysts this Quarter? - Investor Newswire
07/08/16 05:37 PMRecent Analysts Rating Overview: Novavax, Inc. (NASDAQ:NVAX) , ZIOPHARM Oncology Inc (NASDAQ:ZIOP) - Street Updates
07/08/16 05:36 PMBroker Outlook For Novavax, Inc. (NASDAQ:NVAX) - Fiscal Standard
07/07/16 10:30 AMThis Mysterious Number Can Power Your Portfolio To New Highs - [StreetAuthority Network] - Do you follow the 80/20 rule? During the past century this simple ratio has developed into one of the most useful concepts and tools of modern-day routine. In a moment, I'll show you
07/06/16 10:10 AMHC Stocks Review: Novavax, Inc. (NASDAQ:NVAX), Bristol-Myers Squibb Co (NYSE:BMY) - share market updates (press release)
07/06/16 10:10 AMAnalysts Ranking Activities: Novavax, Inc. (NASDAQ:NVAX) , Thermo Fisher Scientific Inc (NYSE:TMO) - Street Updates
07/05/16 05:20 PMTrending Analyst Recommended Stock: Novavax (NVAX) - News Oracle
07/05/16 05:20 PMWhole Foods Market, (NASDAQ:WFM) & Novavax, Inc. (NASDAQ:NVAX) Trader's Watch List - Money News (press release)
07/03/16 04:57 PMShare Performance Recap for: Novavax, Inc. (NASDAQ:NVAX) - Press Telegraph
07/01/16 05:34 PMUpdated Analysts Rating Report: Novavax, Inc. (NASDAQ:NVAX) , Vascular Biogenics Ltd. (NASDAQ:VBLT) - Street Updates
06/30/16 08:26 AMStocks inside Analysts Limelight: Novavax, Inc. (NASDAQ:NVAX) , Envision Healthcare Holdings, Inc. (NYSE:EVHC) - Street Updates
06/29/16 05:27 PMAnalyst Rating Update on Novavax (NVAX) - Trade Calls
06/29/16 05:27 PMPerformance to see: Novavax, Inc. (NASDAQ:NVAX) - News Oracle
06/29/16 08:22 AMMovers to Watch For: NVIDIA Corporation (NASDAQ:NVDA), Novavax, Inc. (NASDAQ:NVAX), Taiwan Semiconductor ... - iStreetWire
06/29/16 08:22 AMAnalyst Rating Fluctuations to Observe: Novavax, Inc. (NASDAQ:NVAX) , Zoetis Inc. (NYSE:ZTS) - Street Updates
06/29/16 08:22 AMNovavax Inc. (NVAX) Jumps 11.16% on June 28 - Equities.com
06/29/16 08:22 AMNovavax Attempts To Clear The $7 Hurdle - Benzinga
06/28/16 05:30 PMNovavax Attempts To Clear The $7 Hurdle
06/28/16 08:07 AMMylan’s Profits: Can You Expect Changes? -
06/28/16 02:36 AMWatch These 5 Huge Put Purchases In Tuesday Trade - Benzinga's newsdesk monitors options activity to notice unusual patterns. These large volume (and often out of the money) trades were initially published intraday in Benzinga Professional . These trades were placed during Monday’s regular session. Novavax, Inc. (NASDAQ: NVAX) Aug16 5.0 Puts Sweep: 1210 @ ...Full story available on Benzinga.com
06/27/16 09:45 AMNovavax, Inc. (NASDAQ:NVAX) Broker Price Targets For The Coming Week - Fiscal Standard
06/26/16 10:04 AMPerformance Overview of the company: Novavax, Inc. (NASDAQ:NVAX) - News Oracle

Social

About Novavax

Novavax logoNovavax, Inc. (Novavax) is a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants. The Company operates through developing recombinant vaccines segment. The Company through its recombinant nanoparticle vaccine technology produces vaccine candidates to respond to both known and newly emerging diseases. Its product pipeline focuses on a range of infectious diseases with vaccine candidates in clinical development for respiratory syncytial virus (RSV), seasonal influenza, pandemic influenza and the Ebola virus (EBOV). Its lead adjuvant for human applications, Matrix-M, is in a Phase I/II clinical trial for pandemic influenza H7N9 vaccine candidate. It is also testing Matrix-M in conjunction with its EBOV vaccine candidate in a Phase I clinical trial. It is developing additional pre-clinical stage programs in a range of infectious diseases, including Middle East respiratory syndrome (MERS).

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: NVAX
  • CUSIP: 67000210
Key Metrics:
  • Previous Close: $7.32
  • 50 Day Moving Average: $7.15
  • 200 Day Moving Average: $5.75
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $1.98B
  • Beta: 1.4
  • Current Year EPS Consensus Estimate: $-0.98 EPS
  • Next Year EPS Consensus Estimate: $-0.88 EPS
Additional Links:
Novavax (NASDAQ:NVAX) Chart for Saturday, July, 30, 2016